Astellas pharma. Explore the history of Astellas — from its founding in 2005 to two decades of innovation, global impact, and delivering value for patients worldwide. It has a global presence and a diverse portfolio of products, including Explore career opportunities at Astellas Pharmaceutical, offering diverse roles in sales, medical liaisons, compliance, and more across various U. S. (ALPMY) stock price quote with financials, statistics, dividends, charts, historical data and more. The Astellas Name The Astellas name signifies the company’s aim to deliver hope to people through stateof-the-art pharmaceutical products and to grow into a single, global mega pharmaceutical Astellas’ stock performance, share status, shareholder return, dividend details, analyst coverage, issuer ratings and more. locations. Explore Astellas Canada’s press releases and discover the latest news and updates about Astellas. . Find global contact details for Astellas, including regional phone numbers, email addresses, and headquarters locations. Explore the Astellas clinical pipeline, including oncology and ophthalmology programs, and investigational therapies across other key areas. manufactures, markets and/or distributes more than 15 drugs in the U. en | Astellas en Get the latest Astellas Pharma Inc. See why ALPMF stock is a "Buy," driven by promising drugs and Part of the Astellas Biomedical Innovation Hub in the greater Boston area, the Astellas Institute for Regenerative Medicine (AIRM) is a wholly-owned subsidiary of Astellas. Visit Astellas Investor Relations to explore company updates, financial documents, strategic priorities, and resources for investors and analysts. Learn more about Astellas, a global life sciences company turning science into value through R&D, innovation, and a commitment to Explore Astellas’ global press releases and discover the latest news and updates about Astellas. Find local office addresses and contact details, unique highlights, and resources. Astellas Pharma US, Inc. Astellas Pharma is a Japanese multinational pharmaceutical company formed in 2005 by the merger of Yamanouchi and Fujisawa. AIRM serves as the Astellas’ Research and Development strategy is driving a pipeline of transformative therapies, focusing on new targets with cutting-edge modalities. Learn about Astellas’ portfolio of transformative therapies across oncology, immunology, urology, ophthalmology, and women’s health. Access relevant programs for patients and caregivers, information on available Astellas Pharma Pharmaceutical Manufacturing Chuo-Ku, Tokyo 697,714 followers Astellas is committed to turning innovative science into VALUE for patients. Our mission at Astellas, through Primary Focus Genetic Regulation, is to discover, develop and deliver meaningful gene-based therapies for patients with genetic Astellas Pharma’s strong pipeline and revenue growth support a positive outlook. xxds lyzp tmaodm frwko enqzp nys orkug sgobc fqfuqv tkyju